Case 1: A 19- year-old man affected by male pattern hair loss (MPHL) received finasteride, 1 mg/d for 8 months. Seven months later, he presented with a painful enlargement of his left breast, with no evident nodules at palpation. On sonography, there was diffuse increase in breast tissue, without any abnormal mass or parenchymal distortion [Figure 1]. Axillary lymph nodes were normal. Laboratory evaluations including testosterone, free testosterone, luteinizing hormone, dehydroepiandrosterone, and prolactin were within normal range. Dihydrotestosterone level was 135 µg/ 100 mL (normal, 133-441). Follicle-stimulating hormone was 1.1 IU/L (normal, 1.4-10.5). 17-hydroxyprogesterone level was elevated at 3.63 ng/mL (normal, 0.5-2.4). The result of semen analysis was normal. Liver function and thyroid function studies were normal. Any other causes of gynecomastia, including other drug-induced gynecomastia and breast cancer, were ruled out in this patient by endocrine consultation. Treatment was stopped, and 4 months later gynecomastia completely disappeared and laboratory tests returned to normal levels. Two months later, the patient was restarted on the finasteride regimen, 1 mg every alternate day, with no relapse of gynecomastia. source: http://www.ijdvl.com/article.asp?is...5;issue=3;spage=309;epage=310;aulast=Mansouri |
You don't think factors like reducing body weight and avoiding estrogenic foods won't impact if I get it again?